化学
细胞凋亡
共晶
苯甲酸
癌症研究
淋巴瘤
结构-活动关系
细胞培养
癌细胞
组合化学
计算生物学
癌症
立体化学
生物化学
体外
遗传学
分子
生物
免疫学
氢键
有机化学
作者
Karson J. Kump,Lei Miao,Ahmed S.A. Mady,Nurul H. Ansari,Uttar K. Shrestha,Yuting Yang,Mohan Pal,Chenzhong Liao,Andrej Perdih,Fardokht A. Abulwerdi,Krishnapriya Chinnaswamy,Jennifer L. Meagher,Jacob M. Carlson,May Khanna,Jeanne A. Stuckey,Zaneta Nikolovska‐Coleska
标识
DOI:10.1021/acs.jmedchem.9b01442
摘要
Anti-apoptotic Bcl-2 family proteins are overexpressed in a wide spectrum of cancers and have become well validated therapeutic targets. Cancer cells display survival dependence on individual or subsets of anti-apoptotic proteins that could be effectively targeted by multimodal inhibitors. We designed a 2,5-substituted benzoic acid scaffold that displayed equipotent binding to Mcl-1 and Bfl-1. Structure-based design was guided by several solved cocrystal structures with Mcl-1, leading to the development of compound 24, which binds both Mcl-1 and Bfl-1 with Ki values of 100 nM and shows appreciable selectivity over Bcl-2/Bcl-xL. The selective binding profile of 24 was translated to on-target cellular activity in model lymphoma cell lines. These studies lay a foundation for developing more advanced dual Mcl-1/Bfl-1 inhibitors that have potential to provide greater single agent efficacy and broader coverage to combat resistance in several types of cancer than selective Mcl-1 inhibitors alone.
科研通智能强力驱动
Strongly Powered by AbleSci AI